Muromonab-CD3 1mg/mL; soln for IV inj ... Periodically monitor Orthoclone OKT3 levels or T cell clearance; children: monitor daily. Elderly. Pregnancy (Cat.C).

These recipients were then used to compare cytokine responses to three different antibody-based therapies known to stimulate cytokine release, including muromonab-CD3 (OKT3), anti-CD28 and an ...

anti-CD3 (OKT3, 200 ng/ml Janssen-Cilag, Neuss, Germany) for 6 h or 4 h, respectively. Freshly prepared TILs from RCC were stimulated for 4 h with 50 ng/ml phorbol 12-myristate 13-acetate and 500 ...